CryoCor PMA To Be Reviewed At FDA Panel

... CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that it has been informed by the U.S. Food and Drug Administration, or FDA, that an Advisory Panel meeting will be convened to review CryoCor's pre-market approval application, or PMA, for the treatment of atrial flutter. [click link for full article] ...